Issue #304
- Efavirenz (SUSTIVA (tm)) Approved
- Crixivan« (Indinavir): Three Doses Daily, Not Two, in Most Regimens
- Amprenavir (Agenerase (tm)) Now Available in Expanded Access
- Successful Standard Treatment for Lipid Abnormalities: Experience with 44 Patients
- ICAAC Conference: Daily Summaries Available
- Abacavir (Ziagen (tm)) Advisory Committee Meeting, November 2
- Prison Treatment Programs: Glaxo-Wellcome Awards 19 Grants
- Iscador Update: Interview with Robert Gorter, M.D.
- United States Conference on AIDS, Dallas, Oct. 29 - Nov. 1
- San Francisco: POZ Life Expo, October 16-17
source: AIDS Treatment News
